21 March 2023
@HybridanLLP
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv ....
21 Mar 2023
Hybridan Small Cap Feast - 21 Mar 23
Tissue Regenix Group plc (TRX:LON), 61.0 | Symphony Environmental Technologies plc (SYM:LON), 3.2 | SpaceandPeople plc (SAL:LON), 106 | Renalytix Plc (RENX:LON), 9.5 | Powerhouse Energy Group PLC (PHE:LON), 1.1 | Fusion Antibodies Plc (FAB:LON), 3.5 | 10X Genomics Inc (TXG:NYSE), 0 | 10x Genomics Inc Class A (TXG:NAS), 0 | Fintel PLC (FNTL:LON), 306
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Hybridan Small Cap Feast - 21 Mar 23
Tissue Regenix Group plc (TRX:LON), 61.0 | Symphony Environmental Technologies plc (SYM:LON), 3.2 | SpaceandPeople plc (SAL:LON), 106 | Renalytix Plc (RENX:LON), 9.5 | Powerhouse Energy Group PLC (PHE:LON), 1.1 | Fusion Antibodies Plc (FAB:LON), 3.5 | 10X Genomics Inc (TXG:NYSE), 0 | 10x Genomics Inc Class A (TXG:NAS), 0 | Fintel PLC (FNTL:LON), 306
- Published:
21 Mar 2023 - Author:
-
Pages:
2
21 March 2023
@HybridanLLP
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv ....